ArticleDiabetologia2011
Diagnosing gestational diabetes: can expert opinions replace scientific evidence?
Article in Diabetologia, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 48 citations in OpenAlex.
- Trial
- The Maternal and Fetal Consequences of Metabolic Dysfunction-Associated Fatty Liver Disease and Gestational Diabetes Mellitus.Nutrients · 2025Review
- The TANGO-DM randomized controlled trial study protocol: treatment outcomes for gestational diabetes diagnosed according to WHO 2013 or WHO 1999 thresholds.BMC pregnancy and childbirth · 2025Article
- Pragmatic trials can address diagnostic controversies: recent lessons from gestational diabetes.Trials · 2022Review
- Prognostic prediction models for pregnancy complications in women with gestational diabetes: a protocol for systematic review, critical appraisal and meta-analysis.Systematic reviews · 2019Article
- Most Women with Previous Gestational Diabetes Mellitus Have Impaired Glucose Metabolism after a Decade.International journal of molecular sciences · 2018Article
- Gestational diabetes mellitus: an updated overview.Journal of endocrinological investigation · 2017Review
- Glucose challenge test (50-g GCT) in detection of glucose metabolism disorders in peritoneal dialysis patients: preliminary study.International urology and nephrology · 2015Article
- Updated guidelines on screening for gestational diabetes.International journal of women's health · 2015Review
- Diabetes in pregnancy among indigenous women in Australia, Canada, New Zealand and the United States.Diabetes/metabolism research and reviews · 2013Review
- Establishing consensus in the diagnosis of gestational diabetes following HAPO: where do we stand?Current diabetes reports · 2013Review
- Gestational diabetes mellitus: screening and outcomes in southern italian pregnant women.ISRN endocrinology · 2013Article
- Gestational diabetes mellitus: risks and management during and after pregnancy.Nature reviews. Endocrinology · 2012Review
- Effect of maternal weight, adipokines, glucose intolerance and lipids on infant birth weight among women without gestational diabetes mellitus.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2012Article
- Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations of maternal A1C and glucose with pregnancy outcomes.Diabetes care · 2012Article
- Gestational diabetes mellitus: implications of an increased frequency with IADPSG criteria.Diabetes care · 2012Article
Corrections and comments
- Comment on
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Preventive medical interventions should be based on the highest level of scientific evidence. Actual criteria for diagnosing gestational diabetes mellitus (GDM) are neither uniform nor based on pregnancy outcomes. An expert panel from the International Association of Diabetes in Pregnancy Study Groups recently proposed that all pregnant women undergo a one-step 75 g OGTT, and defined new lower cut-off points to diagnose GDM (Metzger BE et al. Diabetes Care 33: 676-682). These criteria will double the prevalence of GDM, as 18% of all pregnant women will be labelled as abnormal. A recent article in Diabetologia (Ryan EA 54:480-486) claimed that maternal glucose is a weak predictor of big babies, that a single OGTT is poorly reproducible, and that expected benefits from intervention would be, at best, modest. This Commentary discusses other objections and argues that guidelines on any new GDM diagnostic strategy should be based on the results of randomised controlled trials rather than on disputable expert opinions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.